From owner-metabolic-reg@net.bio.net Sat Dec 11 07:05:04 1999 Path: hgmp.mrc.ac.uk!pegasus.csx.cam.ac.uk!daresbury!uninett.no!howland.erols.net!netnews.com!newshub.northeast.verio.net!verio!nuq-peer.news.verio.net!news.verio.net!nuq-read.news.verio.net.POSTED!dynamic227.as26.snfcca01.pacific.verio.net!user From: cgriffin@wco.com (Chandi Griffin) Newsgroups: bionet.metabolic-reg Subject: ABRF MICROARRAY USER SURVEY Message-ID: Lines: 52 Date: Fri, 10 Dec 1999 23:04:04 -0700 NNTP-Posting-Host: 206.184.58.227 X-Complaints-To: abuse@verio.net X-Trace: nuq-read.news.verio.net 944895798 206.184.58.227 (Sat, 11 Dec 1999 07:03:18 GMT) NNTP-Posting-Date: Sat, 11 Dec 1999 07:03:18 GMT Organization: Verio Xref: hgmp.mrc.ac.uk bionet.metabolic-reg:183 To all investigators involved in microarray technologies: The 1999/2000 ABRF MICROARRAY RESEARCH GROUP STUDY is open for submissions as of December 10, 1999. The goal of this study is to build a current picture of the microarray analysis world. Microarray analysis is a fast developing field. New methods and instrumentation are being constantly introduced and the number of investigators using the technology is rapidly expanding. We are focusing on both Affymetrix and cDNA related technologies. Laboratories using these technologies can participate in our study by filling out a web based survey form. The form is used to collect information such as instrumentation, protocols, staffing, funding, and throughput. This data will be analyzed to build a current profile of microarray analysis laboratories. The survey from is posted at http://brcweb.bio.cornell.edu/surveys/microsurvey.html. The survey is geared to gathering information from academic, pharmaceutical, and commercial laboratories that offer microarray technologies as a shared resource. Individual laboratories that have these technologies are also welcome to participate in the survey. In addition, microarray instrument and related manufacturers are welcome to submit data. However, data from manufacturers must be clearly identified and will be analyzed separately from the pool of data submitted anonymously by all other laboratories. An analysis of data submitted to this survey will be presented at the ABRF2000 meeting in February 2000 (http://www.faseb.org/meetings/abrf2000) and will then be posted on the web. We appreciate your participation in this study. The ABRF Microarray Research Group: George Grills, Albert Einstein College of Medicine, Bronx, NY (chair) Chandi Griffin, Gen. Clin. Res. Ctr., University of California, San Francisco,CA Kathryn Lilley, University of Leicester, UK Aldo Massimi, Albert Einstein College of Medicine, Bronx, NY Yongde Bao, University of Virginia School of Medicine, Charlottesville, VA (ad hoc) Suzanne Sandmeyer, University of California, Irvine, CA (ad hoc) James VanEe, Cornell University, Ithaca, NY (ad hoc) ------------------------------------------------------------------ Please direct questions about participation in this study to George Grills at grills@aecom.yu.edu Chandi Griffin GCRC: Molecular Biology Core Laboratory & GCRC GeneChip Contact Univ. of California, San Francisco/San Francisco General Hospital E-mail: aniya@itsa.ucsf.edu .